sackler family oxycontin

Sackler, Purdue Pharma $7 Billion Lawsuit

Purdue and Sackler family agree to $7.4bn national opioid settlement

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.

CBS News on MSN · 2d

Sackler family, Purdue Pharma reach $7.4 billion settlement with 15 states over opioid crisis

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, New York Attorney General Letitia James announced Thursday.

The Tribune-Democrat · 1d

AG: Pa. part of $7.4B OxyContin settlement proposal with Purdue Pharma, Sackler family

Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of OxyContin as part of the latest legal settlement stemming from

2don MSN

Sackler Family’s Net Worth: How Much Money They’re Worth Now

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

1don MSN

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...

STAT3d

Sacklers reach new $7.4 billion settlement over opioid crisis

In addition, the Sackler family members will no longer control Purdue, which was blamed for helping to jumpstart the opioid crisis through its marketing of OxyContin. The company was accused of ...

OxyContin makers to pay up to $7.4B in new deal

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

Hosted on MSN2d

New $7.4B Sackler Deal Has Unusual Condition

A new settlement has been reached on lawsuits against Oxycontin maker Purdue Pharma and the Sackler family that owns it, seven months after the Supreme Court rejected a $6 billion deal. The $7.4 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results